Tag: scuttling

Amgen, AstraZeneca prep a brodalumab pitch–after scuttling asthma programFierceBiotechAmgen and its partner AstraZeneca are winding up to deliver U.S. and European applications for their big blockbuster hopeful brodalumab for plaque psoriasis by mid-year. But their last shot to push ahead with the drug in asthma ran into defeat, with … View full post on asthma…